Stock Market Today, Feb.: ImmunityBio Surges on Anktiva
Biotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
At age 50, you can make catch-up contributions to enhance your retirement savings. Understand how to take full advantage of this opportunity.
4,560 articlesBiotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
Investors are eyeing kratos (ktos) 2025 earnings as defense programs underpin revenue. This guide breaks down what to...
Visa faces a mix of growth drivers and risks as digital payments expand globally. This piece outlines the visa stock ...
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
A prominent investment firm just showed its hand in energy delivery by buying a large stake in Chesapeake Utilities. ...
A notable investment firm expanded its Sonos position just as the company prepares a fresh product lineup. This move ...
When a well-known fund exits a position, it invites scrutiny. This fund dumped million in Graphic Packaging as shares...
A sharp stock drop often triggers fear, but a sizable buy can signal belief in a company’s growth path. This article ...
Tesla stock has dipped below $400 again, prompting questions about a potential buy. This guide weighs growth drivers ...
A noted market analyst warns that Strategy’s aggressive Bitcoin purchases echo dot-com-era speculation, risking a ste...
A major institutional purchase has put Enviri in the spotlight. This article breaks down what the $43 million buy mea...
When a top executive sells shares as a company commits billions to its hubs, it can spark questions. This article bre...